U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H30N4O3.ClH.2H2O
Molecular Weight 470.99
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENERISANT HYDROCHLORIDE DIHYDRATE

SMILES

O.O.Cl.C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3C=C(C=N3)C(=O)N4CCOCC4

InChI

InChIKey=KAHPJCXENVTTHA-YTNSDAIYSA-N
InChI=1S/C22H30N4O3.ClH.2H2O/c1-18-4-2-9-24(18)10-3-13-29-21-7-5-20(6-8-21)26-17-19(16-23-26)22(27)25-11-14-28-15-12-25;;;/h5-8,16-18H,2-4,9-15H2,1H3;1H;2*1H2/t18-;;;/m1.../s1

HIDE SMILES / InChI
Molecular Formula C22H30N4O3
Molecular Weight 398.4986
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Enerisant is a histamine H3 receptor antagonist. In H3 receptor binding assay using (R)​-​α-​methyl[3H]​histamine, enerisant showed IC50 of 4.9 nM. Enerisant may be useful for the treatment of Alzheimer's disease, schizophrenia, etc.

Approval Year

Unknown
149124
Targets

Targets

Primary TargetPharmacologyConditionPotency
Antagonist
2849
 4.9 nM [IC50]
Patents

Patents

07888354
4
08183387
4
08193176
5
20100267687
3
20110065667
3
20110065668
3
7888354
3
8183387
3
8193176
3
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:48:55 GMT 2025
Edited
by admin
on Mon Mar 31 22:48:55 GMT 2025
Record UNII
0W4IKH51WL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METHANONE, (1-(4-(3-((2R)-2-METHYL-1-PYRROLIDINYL)PROPOXY)PHENYL)-1H-PYRAZOL-4-YL)-4-MORPHOLINYL-, HYDROCHLORIDE, HYDRATE (1:1:2)
Preferred Name English
ENERISANT HYDROCHLORIDE DIHYDRATE
Common Name English
Code System Code Type Description
CAS
1152749-09-1
Created by admin on Mon Mar 31 22:48:55 GMT 2025 , Edited by admin on Mon Mar 31 22:48:55 GMT 2025
PRIMARY
FDA UNII
0W4IKH51WL
Created by admin on Mon Mar 31 22:48:55 GMT 2025 , Edited by admin on Mon Mar 31 22:48:55 GMT 2025
PRIMARY
PUBCHEM
66933454
Created by admin on Mon Mar 31 22:48:55 GMT 2025 , Edited by admin on Mon Mar 31 22:48:55 GMT 2025
PRIMARY
Related Record Type Details
Structure of ENERISANT HYDROCHLORIDE
ANHYDROUS->SOLVATE
Structure of ENERISANT
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of ENERISANT
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966